Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Hypertension. 2021 May 17;78(1):94–103. doi: 10.1161/HYPERTENSIONAHA.121.17248

Table 1. Characteristics of the study population.

Mean (SD) reported for parametric data. Median [IQR] reported for non-parametric data.

Characteristic Mean (SD) or Median [IQR]
Age – yrs 53 (11)

Male sex - % 64%

Race/Ethnicity
White 50%
Black 19%
Asian 6%
Other/Unknown 25%

BMI – kg/m2 31 (6)

Systolic blood pressure – mmHg 149 (21)

Diastolic blood pressure – mmHg 87 (13)

Number of antihypertensive medications 3 (1)

Potassium at diagnosis – mEq/L 3.4 (0.5)

Potassium < 3.5 mEq/L at diagnosis 58%

Potassium at AVS – mEq/L 3.9 (0.7)

Plasma aldosterone concentration – ng/dL 22.8 [16.7–34.0]

Plasma renin activity – ng/mL/h 0.5 [0.2–0.6]

Aldosterone to renin ratio – (ng/dL)/(ng/mL/h) 70 [35–160]

Cross-sectional imaging findings
Normal adrenal glands 16%
Unilateral adrenal nodule 76%
Bilateral adrenal nodules 8%

Unstimulated LI ≥ 2 - % 82%

Unstimulated LI ≥ 4 - % 66%

Stimulated LI ≥ 4 - % 61%

Unilateral intervention - % 69%

Complete or partial clinical success after unilateral intervention 83% (64% partial, 19% complete)

Complete or partial biochemical success after unilateral intervention 93% (6% partial, 87% complete)